In Italy and in the United States there occur: 1) increase in the prescription of tests to estimate the 25-hydroxycholecalciferol blood levels; 2) increase in the number of computerised bone mineralometry carried out for osteoporosis screening and 3) increase of vitamin D prescriptions with the aim of correcting vitamin D deficiency and preventing bone fractures.
None of the three would seem to find justification in the cost-benefit calculation produced by the US Preventive Service Task Force.
The conclusions of such studies are herewith reported. It is also stressed the poor comfortability of general practitioners (only they can allow free access to services and to drugs) to passively prescribe clinical examinations and therapies, that were recommended by various discipline specialists, who were addressed by the patient for a fee while by-passing his general practitioner’s request.